Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roger

Showing results (141-150 of 144) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 144 results.
BMJ Open|January 24, 2018
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)Annette T Y Wong, Carly Mannix, Jared J Grantham, et al.
NEJM Evidence|February 6, 2024
Prescribed Water Intake in Autosomal Dominant Polycystic Kidney DiseaseGopala K Rangan, Annette T Y Wong, Alexandra Munt, et al.
Nephrology (Carlton, Vic.)|May 15, 2025
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 TrialSimon D Roger, Chew Ming Wong, Phisitt Vejakama, et al.
Kidney International|July 22, 2011
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialMichael V Rocco, Robert S Lockridge, Gerald J Beck, et al.
Pageof 15

Showing results (141-150 of 144) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 144 results.
BMJ Open|January 24, 2018
Randomised controlled trial to determine the efficacy and safety of prescribed water intake to prevent kidney failure due to autosomal dominant polycystic kidney disease (PREVENT-ADPKD)Annette T Y Wong, Carly Mannix, Jared J Grantham, et al.
NEJM Evidence|February 6, 2024
Prescribed Water Intake in Autosomal Dominant Polycystic Kidney DiseaseGopala K Rangan, Annette T Y Wong, Alexandra Munt, et al.
Nephrology (Carlton, Vic.)|May 15, 2025
Non-Inferiority of Subcutaneous Efepoetin Alfa Compared to Methoxy Polyethylene Glycol-Epoetin Beta in Stage 3 or 4 CKD Patients: Insights From a Phase 3 TrialSimon D Roger, Chew Ming Wong, Phisitt Vejakama, et al.
Kidney International|July 22, 2011
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal TrialMichael V Rocco, Robert S Lockridge, Gerald J Beck, et al.
Pageof 15